Enterprise Value
2.101B
Cash
54.62M
Avg Qtr Burn
-10.71M
Short % of Float
0.00%
Insider Ownership
80.33%
Institutional Own.
-
Qtr Updated
12/31/22
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
APL-106 Details Acute myeloid leukemia | Phase 3 Update | |
APL-101 Details Glioblastoma, Non-small cell lung carcinoma | Phase 2 Update |